The dopamine D4 receptor: biochemical and signalling properties

Dopamine is an important neurotransmitter that regulates several key functions in the brain, such as motor output, motivation and reward, learning and memory, and endocrine regulation. Dopamine does not mediate fast synaptic transmission, but rather modulates it by triggering slow-acting effects through the activation of dopamine receptors, which belong to the G-protein-coupled receptor superfamily. Besides activating different effectors through G-protein coupling, dopamine receptors also signal through interaction with a variety of proteins, collectively termed dopamine receptor-interacting proteins. We focus on the dopamine D4 receptor, which contains an important polymorphism in its third intracellular loop. This polymorphism has been the subject of numerous studies investigating links with several brain disorders, such as attention-deficit hyperactivity disorder and schizophrenia. We provide an overview of the structure, signalling properties and regulation of dopamine D4 receptors, and briefly discuss their physiological and pathophysiological role in the brain.

[1]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[2]  J. Palacios,et al.  Distribution of 5-ht and Da Receptors in Primate Prefrontal Cortex: Implications for Pathophysiology and Treatment Specifically, It Receives Dopaminergic Efferents from the Ventral Tegmental Area (vta) , 2022 .

[3]  R. Lefkowitz,et al.  Regulation of G protein-coupled receptor signaling by scaffold proteins. , 2002, Circulation research.

[4]  M. Low,et al.  Dopamine D4 Receptor-Deficient Mice Display Cortical Hyperexcitability , 2001, The Journal of Neuroscience.

[5]  A. Grace,et al.  Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning , 2002, Nature.

[6]  J. Tallman,et al.  I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. , 1997, The Journal of pharmacology and experimental therapeutics.

[7]  J. Zhang,et al.  D(4) dopamine receptor differentially regulates Akt/nuclear factor-kappa b and extracellular signal-regulated kinase pathways in D(4)MN9D cells. , 2001, Molecular pharmacology.

[8]  Z. Rónai,et al.  Genotyping the ‐521C/T functional polymorphism in the promoter region of dopamine D4 receptor (DRD4) gene , 2001, Electrophoresis.

[9]  C. Schmauss,et al.  Dopamine receptor functions: lessions from knockout mice , 2001 .

[10]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[11]  H. V. Tol,et al.  The dopamine D4 receptors and mechanisms of antipsychotic atypicality , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  A. S. Bogachuk,et al.  Two adjacent cysteine residues in the C‐terminal cytoplasmic fragment of bovine rhodopsin are palmitylated , 1988, FEBS letters.

[13]  Min Whan Jung,et al.  Plasticity and Memory in the Prefrontal Cortex , 2008, Reviews in the neurosciences.

[14]  P. Seeman,et al.  Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.

[15]  K. Hofmann,et al.  Structure and function of proteins in G-protein-coupled signal transfer. , 1996, Biochimica et biophysica acta.

[16]  L. Naylor,et al.  Investigation of the Role of Conserved Serine Residues in the Long Form of the Rat D2 Dopamine Receptor Using Site‐Directed Mutagenesis , 1996, Journal of neurochemistry.

[17]  K. Davis,et al.  Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. , 1997, Archives of general psychiatry.

[18]  B. Shastry Molecular genetics of attention-deficit hyperactivity disorder (ADHD): an update , 2004, Neurochemistry International.

[19]  K. Fuxe,et al.  Voltage‐dependence of the human dopamine D2 receptor , 2008, Synapse.

[20]  D. Donnelly-roberts,et al.  Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[22]  E. Gershon,et al.  Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. , 1994, Archives of general psychiatry.

[23]  C. Verney,et al.  G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  S. Iversen,et al.  Dopamine: 50 years in perspective , 2007, Trends in Neurosciences.

[25]  A. Getson,et al.  The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group. , 1997, Archives of general psychiatry.

[26]  S. Franklin,et al.  PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. , 1997, The Journal of pharmacology and experimental therapeutics.

[27]  A. Bonci,et al.  Dopamine responsiveness is regulated by targeted sorting of D2 receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[29]  G. Sedvall,et al.  A search for association between schizophrenia and dopamine-related alleles , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[30]  J. Tallman,et al.  II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. , 1997, The Journal of pharmacology and experimental therapeutics.

[31]  E. Tirelli,et al.  Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice , 2003, Behavioural Brain Research.

[32]  J. Vincent,et al.  Evolution and cell biology of dopamine receptors in vertebrates , 2003, Biology of the cell.

[33]  A. Argiolas,et al.  PIP3EA and PD‐168077, two selective dopamine D4 receptor agonists, induce penile erection in male rats: site and mechanism of action in the brain , 2006, The European journal of neuroscience.

[34]  M. Millan,et al.  Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes , 2002, Journal of Pharmacology and Experimental Therapeutics.

[35]  M. Martres,et al.  Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism , 1991, Nature.

[36]  D. Donnelly-roberts,et al.  Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. , 2004, Journal of medicinal chemistry.

[37]  M. Low,et al.  Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli , 1999, The Journal of Neuroscience.

[38]  H. V. Van Tol,et al.  Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. , 1994, Molecular pharmacology.

[39]  R. Deth,et al.  How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. , 2008, Neurotoxicology.

[40]  A. Megens,et al.  Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents. , 2005, Journal of medicinal chemistry.

[41]  Xuechu Zhen,et al.  D4 Dopamine Receptor Differentially Regulates Akt/Nuclear Factor-κB and Extracellular Signal-Regulated Kinase Pathways in D4MN9D Cells , 2001 .

[42]  M. Rubinstein,et al.  Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes. , 2007, European journal of pharmacology.

[43]  P. Marin,et al.  GPCR interacting proteins (GIP). , 2004, Pharmacology & therapeutics.

[44]  U. R. Chowdhury,et al.  Cutting Edge: Stimulation of Dopamine D4 Receptors Induce T Cell Quiescence by Up-Regulating Krüppel-Like Factor-2 Expression through Inhibition of ERK1/ERK2 Phosphorylation1 , 2006, The Journal of Immunology.

[45]  K. Kidd,et al.  The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus , 1996, Human Genetics.

[46]  G. Haegeman,et al.  Resistance of the dopamine D4 receptor to agonist-induced internalization and degradation. , 2010, Cellular signalling.

[47]  M. Nöthen,et al.  Lack of evidence for allelic association between personality traits and the dopamine D4 receptor gene polymorphisms. , 1997, The American journal of psychiatry.

[48]  M. Antonelli,et al.  Autoradiographic Localization of the Putative D4 Dopamine Receptor in Rat Brain , 1997, Neurochemical Research.

[49]  P. Seeman,et al.  Dopamine D4 receptors bind inactive (+)-aporphines, suggesting neuroleptic role. Sulpiride not stereoselective. , 1993, European journal of pharmacology.

[50]  T. Mamiya,et al.  Effects of L‐745,870, a Dopamine D4 Receptor Antagonist, on Naloxone‐Induced Morphine Dependence in Mice , 2004, Annals of the New York Academy of Sciences.

[51]  M Linnoila,et al.  The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. , 1996, Molecular psychiatry.

[52]  Y. Fukumaki,et al.  Cloning and characterization of the 5'-flanking region of the human dopamine D4 receptor gene. , 1997, Biochemical and biophysical research communications.

[53]  D. Grandy,et al.  Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum , 2002, Journal of neurochemistry.

[54]  M. Millan,et al.  Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. , 1997, European journal of pharmacology.

[55]  B. Sommer,et al.  Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L‐745,870 and U‐101958 at human recombinant D4.4 receptors expressed in CHO cells , 1999, British journal of pharmacology.

[56]  D. Helmeste,et al.  Dopamine D4 receptors. , 2000, Japanese journal of pharmacology.

[57]  Marcus R. Munafò,et al.  Association of the Dopamine D4 Receptor (DRD4) Gene and Approach-Related Personality Traits: Meta-Analysis and New Data , 2008, Biological Psychiatry.

[58]  Catherine Tallon-Baudry,et al.  Induced γ-Band Activity during the Delay of a Visual Short-Term Memory Task in Humans , 1998, The Journal of Neuroscience.

[59]  L. Chiodo,et al.  D2S, D2L, D3, and D4 dopamine receptors couple to a voltage‐dependent potassium current in N18TG2 × mesencephalon hybrid cell (MES‐23.5) via distinct G proteins , 1999, Synapse.

[60]  J. Swanson,et al.  Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach , 1998, Molecular Psychiatry.

[61]  Anna Y. Kuznetsova,et al.  A model for modulation of neuronal synchronization by D4 dopamine receptor-mediated phospholipid methylation , 2008, Journal of Computational Neuroscience.

[62]  Y. Itoyama,et al.  A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice , 2008, Experimental Neurology.

[63]  L. Snyder,et al.  Selective reconstitution of human D4 dopamine receptor variants with Gi alpha subtypes. , 2000, Biochemistry.

[64]  P D Leeson,et al.  3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. , 1996, Journal of medicinal chemistry.

[65]  H. V. Van Tol,et al.  Polymorphisms in dopamine receptors: what do they tell us? , 2000, European journal of pharmacology.

[66]  H. V. Van Tol,et al.  The dopamine D(4) receptor: one decade of research. , 2000, European journal of pharmacology.

[67]  M. Millan,et al.  S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: I. Cellular, Electrophysiological, and Neurochemical Profile in Comparison with Ropinirole , 2004, Journal of Pharmacology and Experimental Therapeutics.

[68]  J. Slightom,et al.  D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[69]  H. Michel,et al.  Glycosylation, palmitoylation, and localization of the human D2S receptor in baculovirus-infected insect cells. , 1996, Biochemistry.

[70]  K K Kidd,et al.  A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. , 1993, Human molecular genetics.

[71]  K. Fuxe,et al.  Differential voltage-sensitivity of D2-like dopamine receptors. , 2008, Biochemical and biophysical research communications.

[72]  M. Jackson,et al.  Dopamine D4 receptor mediated inhibition of potassium current in neurohypophysial nerve terminals. , 1998, The Journal of pharmacology and experimental therapeutics.

[73]  R. North,et al.  D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. , 1996, Molecular pharmacology.

[74]  R. Rodgers,et al.  Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze. , 1997, European journal of pharmacology.

[75]  D. Middlemiss,et al.  Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells , 1999, British journal of pharmacology.

[76]  T. Pawson,et al.  SH3 binding domains in the dopamine D4 receptor. , 1998, Biochemistry.

[77]  D. Sibley,et al.  Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera , 1997, Brain Research.

[78]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[79]  D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations. , 1993, The Journal of pharmacology and experimental therapeutics.

[80]  M. Martres,et al.  Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. , 1992, European journal of pharmacology.

[81]  U. Hacksell,et al.  Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-Desmethylclozapine as a D2/D3 Partial Agonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[82]  K. Jellinger Understanding G protein‐coupled receptors and their role in the CNS (Molecular and Cellular Neurobiology) , 2003 .

[83]  H. V. Van Tol,et al.  Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. , 1998, European journal of pharmacology.

[84]  J. M. Kennedy,et al.  Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. , 1998, NIDA research monograph.

[85]  P. Seeman,et al.  Dopamine D4 receptors elevated in schizophrenia , 1993, Nature.

[86]  F. Tarazi,et al.  Regional distribution of dopamine D4 receptors in rat forebrain , 1997, Neuroreport.

[87]  Susan R. George,et al.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.

[88]  M. Millan,et al.  [3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[89]  J. Seamans,et al.  The principal features and mechanisms of dopamine modulation in the prefrontal cortex , 2004, Progress in Neurobiology.

[90]  U. Hacksell,et al.  Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist , 2004, Journal of Pharmacology and Experimental Therapeutics.

[91]  H. Hartman,et al.  Iloperidone binding to human and rat dopamine and 5-HT receptors. , 1996, European journal of pharmacology.

[92]  Lin He,et al.  Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). , 2006, Human molecular genetics.

[93]  B. Bondy,et al.  Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction , 1996, Journal of Neuroimmunology.

[94]  C. Felder,et al.  Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. , 1990, The American journal of physiology.

[95]  N. Lavine,et al.  The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor beta to stimulate ERK1/2. , 2010, Cellular signalling.

[96]  R. Todd,et al.  The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. , 1992, The New biologist.

[97]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[98]  P. Seeman,et al.  Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors , 1998, Molecular Psychiatry.

[99]  S. Chaki,et al.  A selective dopamine D4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile. , 1999, Life sciences.

[100]  J. Swanson,et al.  Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. , 1996, Molecular psychiatry.

[101]  Susumu Tonegawa,et al.  Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions , 2000, The Journal of Neuroscience.

[102]  Zhen Yan,et al.  Dopamine D4 Receptors Regulate AMPA Receptor Trafficking and Glutamatergic Transmission in GABAergic Interneurons of Prefrontal Cortex , 2009, The Journal of Neuroscience.

[103]  J. Smoller,et al.  THE NEUROSCIENCE OF ADHD olecular Genetics of Attention-Deficit / Hyperactivity isorder , 2005 .

[104]  P. Goldman-Rakic,et al.  Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. , 2003, Trends in pharmacological sciences.

[105]  R. De La Garza,et al.  [3H]PNU‐101958, a D4 dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non‐human primate brain , 2000, Synapse.

[106]  G. Milligan,et al.  Human D2 and D4 dopamine receptors couple through β γ G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively , 1998, Neuropharmacology.

[107]  David E Nichols,et al.  WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation , 2009, Behavioural pharmacology.

[108]  M. Low,et al.  Quantitative analysis of the dopamine D4 receptor in the mouse brain , 2000, Journal of neuroscience research.

[109]  M. Matsumoto,et al.  Full-length cDNA cloning and distribution of human dopamine D4 receptor. , 1995, Brain research. Molecular brain research.

[110]  J N Giedd,et al.  Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses , 1998, Molecular Psychiatry.

[111]  K. Neve,et al.  Preferential Interaction between the Dopamine D2 Receptor and Arrestin2 in Neostriatal Neurons , 2004, Molecular Pharmacology.

[112]  Bryan L. Roth,et al.  WAY-100635 is a potent dopamine D4 receptor agonist , 2006, Psychopharmacology.

[113]  Sarah A. J. Reading,et al.  Neurobiology of Schizophrenia , 2006, Neuron.

[114]  K. Neve,et al.  Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. , 1991, Molecular pharmacology.

[115]  M. Caron,et al.  Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. , 1990, Biochemistry.

[116]  D. Pauls The Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[117]  S. Bate,et al.  Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat , 2008, Behavioural pharmacology.

[118]  H. Akil,et al.  Site-directed mutagenesis of the human dopamine D2 receptor. , 1992, European journal of pharmacology.

[119]  M. Geyer,et al.  RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice , 2003, Neuropharmacology.

[120]  S. Otte,et al.  Dopamine D4 receptor signaling in the rat paraventricular hypothalamic nucleus: Evidence of natural coupling involving immediate early gene induction and mitogen activated protein kinase phosphorylation , 2006, Neuropharmacology.

[121]  J. A. Chester,et al.  Mice Lacking Dopamine D4 Receptors Are Supersensitive to Ethanol, Cocaine, and Methamphetamine , 1997, Cell.

[122]  P. Greengard,et al.  Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Xin-Yun Huang,et al.  When a G protein-coupled receptor does not couple to a G protein. , 2007, Molecular bioSystems.

[124]  O. Civelli,et al.  Epinephrine and Norepinephrine Act as Potent Agonists at the Recombinant Human Dopamine D4 Receptor , 1997, Journal of neurochemistry.

[125]  M. Knowles,et al.  Expression and pharmacological characterization of the human D3 dopamine receptor. , 1994, The Journal of pharmacology and experimental therapeutics.

[126]  Marc G Caron,et al.  Desensitization of G protein-coupled receptors and neuronal functions. , 2004, Annual review of neuroscience.

[127]  J. Seamans,et al.  Dopamine Receptor Signaling , 2004, Journal of receptor and signal transduction research.

[128]  C. Ragan,et al.  Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist. , 1997, Trends in pharmacological sciences.

[129]  M. Owen,et al.  An update on the genetics of schizophrenia , 2006, Current opinion in psychiatry.

[130]  P. Greengard,et al.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 , 1984, Nature.

[131]  J. Pernier,et al.  Induced gamma-band activity during the delay of a visual short-term memory task in humans. , 1998, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[132]  C. Schmauss,et al.  Dopamine receptor functions: lessons from knockout mice [corrected]. , 2001, Pharmacology & therapeutics.

[133]  A. Sidhu,et al.  Coupling of dopamine receptor subtypes to multiple and diverse G proteins , 2000, International Journal of Developmental Neuroscience.

[134]  D. Grandy,et al.  Dopamine Receptor Gene Expression in the Human Medial Temporal Lobe , 1994, Neuropsychopharmacology.

[135]  HANS R. BRUNNER Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission , 2000 .

[136]  D. Sibley,et al.  D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP , 2008, Journal of neurochemistry.

[137]  J. Swanson,et al.  Evidence of positive selection acting at the human dopamine receptor D4 gene locus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[138]  J. Girault,et al.  DARPP-32: molecular integration of phosphorylation potential , 2008, Cellular and Molecular Life Sciences.

[139]  R. Ebstein,et al.  Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking , 1996, Nature Genetics.

[140]  W. Yao,et al.  Dopaminergic signaling in dendritic spines. , 2008, Biochemical pharmacology.

[141]  G. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.

[142]  N. Lavine,et al.  Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor. , 2001, Molecular pharmacology.

[143]  D. Collier,et al.  Dopamine D4 receptor subtypes and response to clozapine , 1993, The Lancet.

[144]  Zhen Yan,et al.  Dopamine D4 Receptors Regulate GABAA Receptor Trafficking via an Actin/Cofilin/Myosin-dependent Mechanism* , 2009, Journal of Biological Chemistry.

[145]  K. Neve,et al.  Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors , 1992, Journal of Neurochemistry.

[146]  E. Malchiodi,et al.  Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. , 1997, Brain research. Molecular brain research.

[147]  T. Heffner,et al.  A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agent. , 1999, Journal of medicinal chemistry.

[148]  H. Khorana,et al.  Structure and function in rhodopsin: packing of the helices in the transmembrane domain and folding to a tertiary structure in the intradiscal domain are coupled. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[149]  A. Graybiel,et al.  Activity of striatal neurons reflects dynamic encoding and recoding of procedural memories , 2005, Nature.

[150]  R. Roth,et al.  Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys , 1999, Psychopharmacology.

[151]  T. Arinami,et al.  A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. , 1999, Biochemical and biophysical research communications.

[152]  S. Nelson,et al.  Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder , 1998, Molecular Psychiatry.

[153]  N. Lavine,et al.  G Protein-coupled Receptors Form Stable Complexes with Inwardly Rectifying Potassium Channels and Adenylyl Cyclase* , 2002, The Journal of Biological Chemistry.

[154]  K. Neve,et al.  Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. , 1991, The Journal of pharmacology and experimental therapeutics.

[155]  Alessandro Usiello,et al.  Distinct functions of the two isoforms of dopamine D2 receptors , 2000, Nature.

[156]  Michael E Talkowski,et al.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia. , 2008, Human molecular genetics.

[157]  K. Neve,et al.  Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors , 1999, Psychopharmacology.

[158]  F. Monsma,et al.  Development and characterization of antibodies directed against the mouse D4 dopamine receptor , 1998, The European journal of neuroscience.

[159]  M. Caron,et al.  Differential Regulation of the Dopamine D2and D3 Receptors by G Protein-coupled Receptor Kinases and β-Arrestins* , 2001, The Journal of Biological Chemistry.

[160]  Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands. , 2001, Bioorganic & medicinal chemistry letters.

[161]  A. Rivera,et al.  Differential regional and cellular distribution of dopamine D2‐like receptors: An immunocytochemical study of subtype‐specific antibodies in rat and human brain , 1998, The Journal of comparative neurology.

[162]  M. Millan,et al.  [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. , 1997, The Journal of pharmacology and experimental therapeutics.

[163]  D. Murphy,et al.  Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking , 1996, Nature Genetics.

[164]  J. Sandell,et al.  Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography. , 2000, Nuclear medicine and biology.

[165]  S. Faraone,et al.  Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. , 1999, The American journal of psychiatry.

[166]  E. Borrelli,et al.  Structure and function of dopamine receptors , 2000, Neuroscience & Biobehavioral Reviews.

[167]  S. Tsuji,et al.  Lack of association between dopamine D4 receptor gene and schizophrenia. , 1995, American journal of medical genetics.

[168]  M. Caron,et al.  Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors. , 2006, Biochemical and biophysical research communications.

[169]  G. Haegeman,et al.  BTB Protein KLHL12 Targets the Dopamine D4 Receptor for Ubiquitination by a Cul3-based E3 Ligase* , 2008, Journal of Biological Chemistry.

[170]  M. Brockhaus,et al.  Development and Characterization of Antibodies Against the N Terminus of the Human Dopamine D4 Receptor , 1997, Journal of neurochemistry.

[171]  P. Seeman,et al.  Multiple dopamine D4 receptor variants in the human population , 1992, Nature.

[172]  P. Goldman-Rakic,et al.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.

[173]  K. Livak,et al.  Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[174]  P. Leeson,et al.  Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. , 1997, The Journal of pharmacology and experimental therapeutics.

[175]  H. V. Van Tol,et al.  Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. , 1999, Pharmacogenetics.

[176]  Paul Greengard,et al.  The Neurobiology of Dopamine Signaling , 2004 .

[177]  J. Smoller,et al.  Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[178]  P. Goldman-Rakic,et al.  The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. , 1994, Journal of neurophysiology.

[179]  M. Caron,et al.  Phosphorylation and Palmitoylation of the Human D2L Dopamine Receptor in Sf9 Cells , 1994, Journal of neurochemistry.

[180]  Graeme Milligan,et al.  G Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.

[181]  B. Orser,et al.  A D2 Class Dopamine Receptor Transactivates a Receptor Tyrosine Kinase to Inhibit NMDA Receptor Transmission , 2002, Neuron.

[182]  Ping Zhong,et al.  Dopamine D4 Receptors Modulate GABAergic Signaling in Pyramidal Neurons of Prefrontal Cortex , 2002, The Journal of Neuroscience.

[183]  E. Levin,et al.  Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats , 1999, Neuroscience.

[184]  K. Neve,et al.  Dopamine D2 receptor stimulation of mitogen‐activated protein kinases mediated by cell type‐dependent transactivation of receptor tyrosine kinases , 2005, Journal of neurochemistry.

[185]  H. V. Van Tol,et al.  Folding Efficiency Is Rate-limiting in Dopamine D4 Receptor Biogenesis* , 2005, Journal of Biological Chemistry.

[186]  R. Wise,et al.  The neurobiology of addiction , 2019, Annals of the New York Academy of Sciences.

[187]  S. Dunnett,et al.  The influence of environment and experience on neural grafts , 2001, Nature Reviews Neuroscience.

[188]  M. von Zastrow,et al.  Distinct Dynamin-dependent and -independent Mechanisms Target Structurally Homologous Dopamine Receptors to Different Endocytic Membranes , 1999, The Journal of cell biology.

[189]  S. Ferguson Receptor tyrosine kinase transactivation: fine-tuning synaptic transmission , 2003, Trends in Neurosciences.

[190]  A. Arnsten,et al.  Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology , 2009, CNS Drugs.

[191]  M. Lokhandwala,et al.  Dopamine D2 Receptor Activation Causes Mitogenesis via p44/42 Mitogen-Activated Protein Kinase in Opossum Kidney Cells , 2001 .

[192]  G. Milligan,et al.  Protein-protein interactions at G-protein-coupled receptors. , 2001, Trends in pharmacological sciences.

[193]  J. Leysen,et al.  Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor. , 2006, Life sciences.

[194]  H. V. Van Tol,et al.  Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants , 1995, Journal of neurochemistry.

[195]  D. Grandy,et al.  Molecular diversity of the dopamine receptors. , 1993, Annual review of pharmacology and toxicology.

[196]  P S Goldman-Rakic,et al.  Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex , 1998, Synapse.

[197]  N. M. Lind,et al.  Effects of dopamine D4 receptor antagonist on spontaneous alternation in rats , 2008, Behavioral and Brain Functions.

[198]  D. Sibley,et al.  New insights into dopaminergic receptor function using antisense and genetically altered animals. , 1999, Annual review of pharmacology and toxicology.

[199]  A. Faure,et al.  Lesion to the Nigrostriatal Dopamine System Disrupts Stimulus-Response Habit Formation , 2005, The Journal of Neuroscience.

[200]  J. Obeso,et al.  Levodopa therapy for Parkinson's disease: Challenges and future prospects , 2008, Movement disorders : official journal of the Movement Disorder Society.